Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 248-953-3 | CAS number: 28305-25-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics, other
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Reason / purpose for cross-reference:
- read-across source
- Conclusions:
- Calcium and chloride are essential constituents and two of the most abundant ions in all animal species. In adult humans, the total calcium in the body is approx. 830-1100 g. Ninety-nine percent of the calcium is retained in skeletons. Hormonal systems maintain a relatively constant calcium concentration of about 100 µg/mL in the plasma by controlling the intestinal absorption of dietary calcium, the release of calcium from bones, and renal absorption/excretion. Excess calcium is excreted in the urine via glomerulal filtration. Chloride is the most abundant anion in all animal species. In adult humans, the total chloride in the body is approx. 70-95 g. Eighty percent of the chloride is located extracellularly. The intracellular concentration of chloride is approx. 100-140 µg/mL. The chloride concentration in plasma is maintained around 3.55-3.90 mg/mL although chloride is absorbed efficiently from the intestine. Chloride is excreted from the renal tubular lumen by active transport systems, and also by passive diffusion.
- Executive summary:
In the published review document OECD SIDS (2002), the following information is provided on toxicokinetics, metabolism, mechanisms of action of calcium chloride:
Toxicokinetics, Metabolism and Distribution
Calcium chloride is easily dissociated into calcium and chloride ions in water. The absorption, the distribution and the excretion of the ions in animals are regulated separately. Calcium chloride exerts its irritating property to tissues directly in contact with the compound. Once calcium chloride is taken up, the effect of the substance on animals should be attributed to the effect of calcium ions, the effect of chloride ions, or both. The homeostasis and mechanisms of action of calcium and chloride ions are well reviewed in standard textbooks on pharmacology, physiology, biochemistry and nutritional science.
Metabolism, biotransformation and kinetics
Calcium is the most abundant inorganic constituent of all animal species and has an important role in the nutrition of animals. In adult humans, the total calcium in the body is approx. 830-1100 g. Ninety-nine percent of the calcium is retained in skeletons. Hormonal systems maintain a relatively constant calcium concentration of about 100 µg/mL in the plasma by controlling the intestinal absorption of dietary calcium, the release of calcium from bones, and renal absorption/excretion. Excess calcium is excreted in the urine via glomerulal filtration. The renal tubules are able to excrete as well as reabsorb calcium. Thus the tubules are able to produce efficiently a net excretion of calcium to achieve homeostasis when abnormally high levels of calcium are ingested. A significant increase in the calcium concentration in plasma will only occur after high calcium intake in conjunction with other disorders that alter calcium homeostasis, such as renal insufficiency and primary hyperthyroidism [1, 2, 3, 4].
Chloride is the most abundant anion in all animal species. In adult humans, the total chloride in the body is approx. 70-95 g. Eighty percent of the chloride is located extracellularly. The intracellular
concentration of chloride is approx. 100-140 µg/mL. The chloride concentration in plasma is maintained around 3.55-3.90 mg/mL although chloride is absorbed efficiently from the intestine.
Chloride is excreted from the renal tubular lumen by active transport systems, and also by passive diffusion [1, 2].
Mechanisms of action
Calcium is indispensable for the formation and maintenance of bones and teeth, and for the regulation of various physiological functions in all animal species. These include the regulation of neural transmission and muscle contraction, coagulation of the blood, cell membrane integrity, theactivity of several enzymes, and the regulation of the acid-base balance [1, 2, 3]. Chloride is important in the regulation of osmotic and acid-base balances of the body fluids. Chloride maintains electrochemical neutrality by anion exchange with bicarbonate (the chloride shift) in the CO2 transport in the blood red cells [1, 2].
Conclusion
Calcium chloride is easily dissociated into calcium and chloride ions in water. The absorption, the distribution and the excretion of the ions in animals are regulated separately. Calcium and chloride are essential constituents of the body of all animal species. Calcium is essential for the formation of skeletons and the regulation of neural transmission, muscle contraction and coagulation of the blood. Chloride is required for regulating intracellular osmotic pressure and buffering.
References:
(1) Ganong, W.F. (2001). Review of Medical Physiology, 20th ed., McGraw-Hill Medical Publishing Division, New York.
(2) Gomei, T. (chief ed.) (1998). Eiyougaku Handobukku (Handbook of Nutritional Science), 3rd ed., Gihoudou Publishing Co., Tokyo.
(3) Marcus, R. (2001). Agents affecting calcification and bone turnover: calcium, phosphate, parathyroid hormon, vitamin D, calcitonin, and other compounds. In Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 10th ed. (Hardman, J.G. and Limbird, L.E., eds.), McGraw-Hill Medical Publishing Division, New York, pp. 1715-1743.
(4) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes (1999). Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academy Press, Washington, D.C.
- Endpoint:
- basic toxicokinetics
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- For details and justification of read-across please refer to the read-across report attached to IUCLID section 13.
- Reason / purpose for cross-reference:
- read-across source
- Conclusions:
- In the evaluation of the use of lactic acid as the active substance in biocidal products, the natural occurrence of lactic acid in human food and the human body, as well as the role of the compound in human metabolism and physiology should be taken into account. This means that, when the risk for its use in biocidal products is assessed, the natural exposure to lactic acid in food and via endogenous sources, as well as exposure via the use of lactic acid as a food additive should be considered.
In the present report it is concluded that lactic acid can no longer be considered as a “dead-end” waste product of human metabolism, but should instead be seen to play an important role in cellular, regional, and whole body metabolism. Lactic acid has been detected in blood, several other body fluids and tissues. Concentrations of lactic acid increase significantly during intense exercise. At rest, blood concentrations have been reported of 1-1.5 mMol/L (90.1-135.12 mg/L), which can increase up to 10 mMol/L (900.8 mg/L) during exercise.
External human exposure to lactic acid can occur via its natural presence in food, for example in fruit, vegetables, sour milk products, and fermented products such as sauerkraut, yogurt and beer. Based on the available information on concentrations of lactic acid in some of these products, an estimate of the daily consumption of lactic acid due to its natural presence in food was made using the ‘FAO/WHO standard European diet’. A (minimum) daily intake of 1.175 g/person/day was calculated using the available information.
Another source of external exposure is its use as food additive; as such it is authorized in Europe (E270) and the United States (generally recognized as safe = GRAS). A daily intake of 1.65-2.76 g/person/day was estimated using the “Per Capita times 10” method, based on the amount of lactic acid put onto the market (EU and USA) as a food additive by Purac.
Based on the high levels of lactic acid in the human body and in human food, and its use as food additive, the evaluation of the human health effects of lactic acid should first and for all be based on a comparison of this background exposure and the potential contribution of lactic acid in biocidal products to these levels. Therefore, a risk assessment should not be based on the comparison with effects of exposure, but on the comparison with the total daily intake of lactic acid via food, both naturally and as food additive, which was estimated to be 2.8 g/person/day. When the application of Purac’s products will not result in a systemic exposure that contributes substantially to the total systemic exposure, many of the standard human toxicological studies dealing with systemic effects are deemed superfluous. - Executive summary:
The natural occurrence of lactic acid in human food and the human body, as well as the role of the compound in human metabolism and physiology is of primary importance in the understanding of the metabolism and toxicology of lactic acid. This means that, in risk assessment, the natural exposure to lactic acid in food and via endogenous sources, as well as exposure via the use of lactic acid as a food additive should be considered.
In the present report it is concluded that lactic acid, in contrast to previously held belief, can no longer be considered as a “dead-end” waste product of human metabolism, but should instead be seen to play an important role in cellular, regional, and whole body metabolism. Lactic acid has been detected in blood, several other body fluids and tissues. Concentrations of lactic acid increase significantly during intense exercise. At rest, blood concentrations have been reported of 1-1.5 mMol/L (90.1-135.12 mg/L), which can increase up to 10 mMol/L (900.8 mg/L) during exercise.
External human exposure to lactic acid can occur via its natural presence in food, for example in fruit, vegetables, sour milk products, and fermented products such as sauerkraut, yogurt and beer. Based on the available information on concentrations of lactic acid in some of these products, an estimate of the daily consumption of lactic acid due to its natural presence in food was made using the ‘FAO/WHO standard European diet’. A (minimum) daily intake of 1.175 g/person/day was calculated using the available information.
Another source of external exposure is its use as food additive; as such it is authorized in Europe (E270) and the United States (generally recognized as safe = GRAS). A daily intake of 1.65-2.76 g/person/day was estimated using the “Per Capita times 10” method, based on the amount of lactic acid put onto the market (EU and USA) as a food additive by Purac.
Based on the high levels of lactic acid in the human body and in human food, and its use as food additive, the evaluation of the human health effects of lactic acid should first and for all be based on a comparison of this background exposure and the potential contribution of lactic acid in biocidal products to these levels. Therefore, a risk assessment should not be based on the comparison with effects of exposure, but on the comparison with the total daily intake of lactic acid via food, both naturally and as food additive, which was estimated to be 2.8 g/person/day. When the application of Purac’s products will not result in a systemic exposure that contributes substantially to the total systemic exposure, many of the standard human toxicological studies dealing with systemic effects are deemed superfluous.
This information is used in a read-across approach in the assessment of the target substance. For details and justification of read-across please refer to the read-across report attached to IUCLID section 13.
- Endpoint:
- basic toxicokinetics in vitro / ex vivo
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Justification for type of information:
- For details and justification of read-across please refer to the read-across report attached to IUCLID section 13.
- Reason / purpose for cross-reference:
- read-across source
- Preliminary studies:
- The protein content of the nasal epithelium homogenate was determined to be 15.3 mg per mL. The increase of absorbance towards p-nitro-phenylbutyrate of the nasal epithelium homogenate using 15.3 µg of protein was 0.191 ± 0.006 (n= 2), corresponding to an esterase activity of 0.71 ± 0.02 µmol per min per mg of epithelial protein. The rate of chemical hydrolysis was investigated with the three smaller lactate esters methyl, ethyl and isopropyl-S-lactate in 0.05 M phosphate buffer pH 7.0 at 37 °C. The lactate esters were incubated at a concentration of 500 µM for 5 and 20 minutes, and 1, 3 and 19.5 hours. The rate of chemical hydrolysis was very low. Liberated L-lactic acid was only detected for methyl lactate and after 19.5 hours (6.1 mol corresponding to 1.2 % of the total amount of ester). Metabolism of L-lactic acid (buffered) was not observed when L-lactic acid was incubated with nasal epithelium homogenate. The use of inhibitors to prevent enzymatic oxidation to pyruvate was therefore not necessary. The recovery of L-lactic acid, as added to the incubation mixture in the absence of esters, was 91-93%. Using a set of enzymatic incubations of ethyl-S-lactate without addition of buffer, the effect on the pH was measured as a function of incubation time. At the last time point (150 min), the amount of protons detected was approximately 20-fold less than the amount of lactic acid produced. An initial lag phase was observed in the detection of protons: an increase in proton concentration was only measured after 60 minutes of incubation. This lag phase cannot be completely explained by the difference between rate of appearance of lactic acid and protons (as a consequence of the buffer present in the nasal epithelium homogenate), since the slope of the two curves after this lag phase still differed considerably.
- Type:
- metabolism
- Results:
- The following kinetic parameters of the enzymatic hydrolysis of ethylhexyl-S-lactate by rat olfactory epithelium homogenate: KM: 0.17 mM; Vmax: 420 nmol/min/mg protein.
- Metabolites identified:
- yes
- Details on metabolites:
- L-lactic acid is formed by enzymatic hydrolysis of ethylhexyl-S-lactate by carboxylesterase present in rat nasal olfactory tissue.
- Conclusions:
- In an in vitro study to assess the hydrolysis of L-lactate esters by rat nasal olfactory epitheliun homogenate the following observations were made:
Lactic acid is formed by enzymatic hydrolysis of ethylhexyl-S-lactate by carboxylesterase present in rat nasal olfactory tissue. Kinetic parameters of the enzymatic hydrolysis of ethylhexyl-S-lactate by rat olfactory epithelium homogenate were: Km = 0.17 mM and Vmax = 420 nmol/min/mg protein. In general, the olfactory epithelium carboxylesterase showed increasing capacity (increasing Vmax) and affinity (decreasing Km) towards L-lactate esters with increasing molecular weight of the alkyl group. From a large discrepancy between the amount of lactic acid formed and the increase in proton concentration even in very poorly buffered systems it is suggested that a certain defense against acidification exists. - Executive summary:
The hydrolysis of ethylhexyl-S-lactate by rat nasal olfactory epithelium homogenate was investigated in vitro. The ester was incubated with male Wistar rat olfactory epithelium at pH 7.0 and 37 °C. The amount of liberated L-lactic acid (buffered) was quantified at a series of time points, from which the initial rate of hydrolysis was estimated. Using a concentration range of 0.05–0.8 mM, the enzyme kinetic parameters were calculated to be Km = 0.17 mM and Vmax = 420 nmol/min/mg protein. Based on these values, the calculated half-life of the enzymatic hydrolysis of ethylhexyl-S-lactate is 0.0004 min or 0.024 sec.
Seven other lactate esters were also tested. In general, the olfactory epithelium carboxylesterase showed increasing capacity (increasing Vmax) and affinity (decreasing Km) towards L-lactate esters with increasing molecular weight of the alkyl group.
Since the pKa value of lactic acid is 3.80, the formation of lactic acid will (in non-buffered systems) directly result in acidification of the solution. However, even in poorly buffered systems (non-buffered incubation mix) a large discrepancy between the amount of lactic acid formed and the increase in proton concentration is observed. This suggest that a certain defense against acidification exists, and that in vivo, only high doses and/or prolonged exposure will result in acidification of tissues.
Referenceopen allclose all
The role of lactic acid in metabolism has kept researchers occupied for a long time. For many years, lactic acid was considered a dead-end waste product of the glycolysis, the conversion of glucose into pyruvate (producing a relatively small amount of ATP), in the absence of oxygen. Recently, the role of lactic acid in metabolism was reconsidered, and L-lactate is considered as a functional metabolite and mammalian fuel. It was observed that lactate can be transferred from its site of production (cytosol) to neighbouring cells and other organs, as well as intracellularly, where its oxidation or continued metabolism can occur. This "lactate shuttle" results in the distribution of lactic acid to other cells, where it is directly oxidised, re-converted back to pyruvate or glucose, allowing the process of glycolysis to restart and ATP provision maintained.
Kinetic parameters of the enzymatic hydrolysis of ethylhexyl-S-lactate by rat olfactory epithelium homogenate were: Km = 0.17 mM and Vmax = 420 nmol/min/mg protein.
Description of key information
Calcium (S)-lactate fully dissociates into Ca2+ ions and L(+)-lactic acid in aqueous solutions and/or under physiological conditions. The toxicological effects of Calcium (S)-lactate can be understood in terms of the toxicological effect of lactic acid and calcium chloride. Lactic acid is a ubiquitous and essential biological molecule in humans and other mammals, but also in most if not all vertebrate and invertebrate animals, as well as in many micro-organisms. Therefore, the biokinetics, metabolism and distribution of lactic acid have to be considered in the context of its normal biochemistry; lactic acid is of minor toxicological concern given its ubiquitousness and function as a common metabolite.
Calcium and chloride are essential constituents and two of the most abundant ions in all animal species. In adult humans, the total calcium in the body is approx. 830-1100 g. Ninety-nine percent of the calcium is retained in skeletons. Hormonal systems maintain a relatively constant calcium concentration of about 100 µg/mL in the plasma by controlling the intestinal absorption of dietary calcium, the release of calcium from bones, and renal absorption/excretion. Excess calcium is excreted in the urine via glomerulal filtration. Chloride is the most abundant anion in all animal species. In adult humans, the total chloride in the body is approx. 70-95 g. Eighty percent of the chloride is located extracellularly. The intracellular concentration of chloride is approx. 100-140 µg/mL. The chloride concentration in plasma is maintained around 3.55-3.90 mg/mL although chloride is absorbed efficiently from the intestine. Chloride is excreted from the renal tubular lumen by active transport systems, and also by passive diffusion.
Ethylhexyl lactate is a suitable read-across partner to the target substance Calcium (S)-lactate due the common hydrolysis/dissociation product lactic acid/lactate (Bogaards & van Ommen, 2000). In this study, Ethylhexyl lactate was incubated with male Wistar rat olfactory epithelium at pH 7.0 and 37 °C. The amount of liberated L-lactic acid (buffered) was quantified at a series of time points, from which the initial rate of hydrolysis was estimated. Using a concentration range of 0.05–0.8 mM, the enzyme kinetic parameters were calculated to be Km = 0.17 mM and Vmax = 420 nmol/min/mg protein. Based on these values, the calculated half-life of the enzymatic hydrolysis of Ethylhexyl-lactate is 0.0004 min or 0.024 sec. Accordingly, toxicity studies using Ethylhexyl lactate as test substance actually measure the effects of the hydrolysis products lactic acid and Ethylhexanol. Effect levels (e.g. NOAELs) from such studies, extrapolated to lactate, are therefore protective with respect to any effects potentially exerted by lactate/lactic acid.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
